- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT02596698
Mitochondrial Dysfunction, Inflammation, and White Matter Integrity in Youth With Mood Disorders
Aperçu de l'étude
Statut
Description détaillée
This is a research study looking at the biology of mood disorders in youth. The investigator ask participants to come in for three visits. The first visit includes a diagnostic interview, some questionnaires, and a blood draw. The blood draw will take place at the Fairview Outpatient Lab. A trained technician will take about 4 teaspoons of blood from the participant's arm. This sample will be sent to Dr. Andreazza in Toronto, Ontario for further analysis. No results will be shared with the participant.
The second visit would take place at the Fairview Riverside Ambulatory Research Center (ARC). This appointment will include the Trier Social Stress Test (TSST). For this, participants will be asked to prepare a short speech for 5 minutes and deliver that speech for in front of an audience with another task to follow. This task will be videotaped. After the participant has completed the speech task, the participant will be asked to complete a number of laptop games which will test for things like attention and memory. Participants will be asked to provide 5 saliva samples throughout the course of this visit so the investigators can look at Cortisol which is a hormone naturally found in saliva. The investigators will also ask participants to complete an additional set of 5 spit samples at home during the course of a normal day and bring those back to their next appointment.
The third visit would take place at the Center for Magnetic Resonance Research (CMRR) and would include a brain MRI. The MRI scan is noninvasive and takes about 2 hours. Participants will be asked to provide a urine sample and complete a urine toxicology screen (drug test) and pregnancy test (if female) prior to the MRI scan. Participants may not participate if drug or pregnancy testing is positive. The MRI involves taking pictures of the brain, from which measures of the integrity of certain brain tissues can be derived. For the scan, participants will be asked to lie down quietly on a scanner bed. Once they are inside the scanner, it will start to take pictures. While in the scanner, participants will be doing things like resting, or listening to music.
Type d'étude
Inscription (Réel)
Contacts et emplacements
Lieux d'étude
-
-
Minnesota
-
Minneapolis, Minnesota, États-Unis, 55454
- Ambulatory Research Center (ARC)
-
Minneapolis, Minnesota, États-Unis, 55455
- Center for Magnetic Resonance Research
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
Accepte les volontaires sains
Sexes éligibles pour l'étude
Méthode d'échantillonnage
Population étudiée
La description
Inclusion Criteria - All Participants:
- Age 13-18 years old
- Both child and guardian are English speaking
Inclusion Criteria - Patient Group:
- Has a diagnosis of a depressive disorder, a bipolar spectrum disorder (type 1, type 2, Unspecified), or an unspecified mood disorder based on the Diagnostic Statsitical Manual 5 (DSM-5)
Inclusion Criteria - Healthy Controls
- Does not meet criteria for any psychiatric disorders based on the DSM-5
- Does not have a family history of psychotic or mood disorders in first degree relative
Exclusion Criteria:
- Past history of brain damage, a seizure disorder, increased intracranial pressure, history of head trauma with loss of consciousness for >15 minutes, history of stroke, mental retardation, or other serious neurological disorder
- MRI contraindications such as braces, metal implants, implanted medical devices, or claustrophobia
- Intelligence quotient < 80
- Severe or acute medical illness
- A history of current (past 3 months) substance disorder (defined by DSM-5) with the exception of Nicotine
- Refusal to cooperate with study procedures
- Active suicidal ideation with intent
- Self-injury that requires medical attention (e.g. stitches) or gets significantly worse during the course of the study
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
Cohortes et interventions
Groupe / Cohorte |
|---|
|
Adolescents with Mood Disorders
Teens aged 13-18 with a diagnosis of a mood disorder.
|
|
Adolescents with no Mental Health Diagnoses
13-18, no psychiatric d/o diagnosis
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Blood Analysis
Délai: Baseline
|
Blood samples will be analysed for mitochondrial dysfunction and resulting oxidative damage to lipids, and protein and messenger ribonucleic acid levels of inflammatory cytokines
|
Baseline
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
MRI Data
Délai: Up to 6 weeks after baseline
|
White matter integrity.
Diffusion imaging data will be processed, following registration and motion correction, using a probabilistic tractography approach that will define and extract parameters such as fractional anisotrophy and radial diffusion from fiber bundles of interest.
In this study we will focus on white matter tracts connecting fronto-limbic brain regions.
Details about the tractography procedures can be found at http://surfer.nmr.mgh.harvard.edu/fswiki/Tracula
|
Up to 6 weeks after baseline
|
|
Saliva Cortisol
Délai: Up to 6 weeks of baseline
|
Stress Functioning.
Saliva samples from the Trier Social Stress Test will be stored in a freezer and sent as a complete batch to Trier, Germany.
We will conduct repeated measures ANOVA tests on the cortisol data and examine group and group x time interactions.
We will calculate the Area Under the Curve for each person's pattern of cortisol responses over time, and these values will be used in multivariate regression analyses below.
|
Up to 6 weeks of baseline
|
|
Beck Depression Inventory (BDI-II)
Délai: Baseline and within 6 weeks of baseline
|
Measures levels of depression in participants.
Has information on suicidal ideation.
If participants are suicidal, a member of research staff will talk with the participant and develop a safety plan with the adolescent and their parent.
|
Baseline and within 6 weeks of baseline
|
|
Children's Depression Rating Scale - Revised (CDRS-R)
Délai: Baseline
|
Measures levels of depression in participants.
Has information on suicidal ideation.
If participants are suicidal, a member of research staff will talk with the participant and develop a safety plan with the adolescent and their parent.
|
Baseline
|
Collaborateurs et enquêteurs
Parrainer
Collaborateurs
Les enquêteurs
- Chercheur principal: Kathryn R Cullen, MD, University of Minnesota
- Chercheur principal: Ana Andreazza, PhD, University of Toronto, Ontario
- Chercheur principal: Bonnie Klimes-Dougan, PhD, University of Minnesota
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Réel)
Achèvement primaire (Réel)
Achèvement de l'étude (Réel)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Estimation)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Mots clés
Termes MeSH pertinents supplémentaires
Autres numéros d'identification d'étude
- 1507M75201
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .